Federal health advisors voted 17-1 against an experimental treatment for Lou Gehrig’s disease dubbed NurOwn, although the FDA is not bound by the vote. Source
Federal health advisors voted 17-1 against an experimental treatment for Lou Gehrig’s disease dubbed NurOwn, although the FDA is not bound by the vote. Source